Baird raised the firm’s price target on Healthcare Services (HCSG) to $15 from $13 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results and noted the recent Big Beautiful Bill impact will take some time.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG: